Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 41 Magnetic Resonance Spectroscopy 27 Biopsy 17 Gemcitabine 16 fludarabine 15 Cyclophosphamide 15 Carboplatin 15 Paclitaxel 13 Oxaliplatin 12 Cisplatin 12 Dexamethasone 11 pembrolizumab 9 Radiotherapy 9 Nivolumab 9 Irinotecan 9 Interviews as Topic 9 Injections 8 Fluorouracil 8 Drug Therapy 8 venetoclax 7 cemiplimab 7 Radiosurgery 7 Capecitabine 7 Bevacizumab 7 durvalumab 6 X-Rays 6 Rituximab 6 Neoadjuvant Therapy 6 Doxorubicin 6 Calcium Dobesilate 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × penpulimab × 30 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡